 MONMOUTH JUNCTION, N.J., July 19, 2021 PRNewswire -- CytoSorbents Corporation NASDAQ: CTSO a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, will report second quarter 2021 operating and financial results after the market close on August 3, 2021. 